Determination of naproxen in pharmaceuticals by differential pulse voltammetry at a platinum electrode

被引:79
作者
Adhoum, N
Monser, L
Toumi, M
Boujlel, K
机构
[1] Inst Natl Sci Appl & Technol, Dept Chim, Tunis 1080, Tunisia
[2] Fac Sci Tunis, Dept Chim, Lab Chim Analyt & Electrochim, El Manar 1002, Tunisia
关键词
differential pulse voltammetry; naproxen; platinum electrode; tablet analysis;
D O I
10.1016/S0003-2670(03)00922-X
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The anodic oxidation of naproxen has been carried out on a platinum electrode using cyclic, linear sweep and differential pulse voltammetry (DPV). Naproxen exhibited a single well-defined and irreversible peak in acetonitrile/0.1 M LiClO4 with a peak potential at 1146 mV versus Ag/AgCl. This allowed the development of a simple, selective and sensitive differential pulse voltammetric method for the determination of naproxen in pharmaceuticals. The calibration plot was linear (R-2 = 0.998) over the range 1-25 mug ml(-1). The limit of detection (3sigma/m) was 0.24 mug ml(-1) and the relative standard deviation of the measurements was 1.2% (n = 6). Well-defined peaks for two related compounds to naproxen (2-methoxy-6-ethylnaphthalene (MEN) and 2-acetyl-6-metho-xynaphthalene (AMN)) were detected, respectively, at 1096 and 1316 mV versus Ag/AgCl and no interference was measured during the determination of naproxen. The limits of detection of MEN and AMN were found to be respectively 0.28 and 0.21 mug ml(-1). The method was successfully applied to the determination of naproxen in commercial tablets and showed a good sensitivity and accuracy with mean recoveries between 99.8 and 101.2%. (C) 2003 Published by Elsevier B.V.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 16 条
[1]  
BOYNTON C S, 1988, Journal of Clinical Pharmacology, V28, P512
[2]   High-performance liquid chromatographic method development and validation for the simultaneous quantitation of naproxen sodium and pseudoephedrine hydrochloride impurities [J].
Ekpe, A ;
Tong, JH ;
Rodriguez, L .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2001, 39 (03) :81-86
[3]  
FAZEMIFARD AG, 1990, J CHROMATOGR B, V533, P125
[4]   DIFFERENTIAL PULSE POLAROGRAPHIC-DETERMINATION OF SOME CARCINOGENIC NITROSAMINES [J].
HASEBE, K ;
OSTERYOUNG, J .
ANALYTICAL CHEMISTRY, 1975, 47 (14) :2412-2418
[5]  
KANOUTE G, 1983, B SOC CHIM FR, V1, P49
[6]   EXTRACTIONLESS HPLC METHOD FOR THE DETERMINATION OF NAPROXEN IN HUMAN PLASMA AND URINE [J].
KARIDAS, T ;
AVGERINOS, A ;
MALAMATARIS, S .
ANALYTICAL LETTERS, 1993, 26 (11) :2341-2348
[7]   Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents [J].
Li, JJ ;
Norton, MB ;
Reinhard, EJ ;
Anderson, GD ;
Gregory, SA ;
Isakson, PC ;
Koboldt, CM ;
Masferrer, JL ;
Perkins, WE ;
Seibert, K ;
Zhang, Y ;
Zweifel, BS ;
Reitz, DB .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (09) :1846-1856
[8]   Simultaneous determination of caffeine and non-steroidal anti-inflammatory drugs in pharmaceutical formulations and blood plasma by reversed-phase HPLC from linear gradient elution [J].
Martín, MJ ;
Pablos, F ;
González, AG .
TALANTA, 1999, 49 (02) :453-459
[9]  
MATSUMOTO S, 1997, J CHROMATOGR, V692, P375
[10]   Simultaneous analysis of naproxen, nabumetone and its major metabolite 6-methoxy-2-naphthylacetic acid in pharmaceuticals and human urine by high-performance liquid chromatography [J].
Mikami, E ;
Goto, T ;
Ohno, T ;
Matsumoto, H ;
Nishida, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 23 (05) :917-925